Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.
The cutaneous human papillomavirus (HPV) 8 is clearly involved in skin cancer development in epidermodysplasia verruciformis patients and its early genes E2, E6, and E7 have been implicated in cell transformation in vitro. To examine the functions of these genes in vivo we integrated the complete early region of HPV8 into the genome of DBA/Bl6 mice. To target their expression to the basal layer of the squamous epithelia the transgenes were put under the control of the keratin-14 promoter. Transgenic mice were back-crossed for up to six generations into both FVB/N and Bl6 mouse strains. Whereas none of the HPV8 transgene-negative littermates developed lesions in the skin or any other organ, 91% of HPV8-transgenic mice developed single or multifocal benign tumors, characterized by papillomatosis, acanthosis, hyperkeratosis, and varying degrees of epidermal dysplasia. Squamous cell carcinomas developed in 6% of the transgenic FVB/N mice. Real-time reverse transcription-PCR showed highest expression levels for HPV8-E2, followed by E7 and E6. There was no consistent difference in relative viral RNA levels between healthy or dysplastic skin and malignant skin tumors. Whereas UV-induced mutations in the tumor suppressor gene p53 are frequently detected in human skin carcinomas, mutations in p53 were not observed either in the benign or malignant mouse tumors. Nonmelanoma skin cancer developed in HPV8-transgenic mice without any treatment with physical or chemical carcinogens. This is the first experimental proof of the carcinogenic potential of an epidermodysplasia verruciformis-associated HPV-type in vivo.
Schaper
Inke Diana
ID
Institute of Virology, Center for Molecular Medicine Cologne, University of Cologne, Germany.
Marcuzzi
Gian Paolo
GP
Weissenborn
Sönke Jan
SJ
Kasper
Hans Udo
HU
Dries
Volker
V
Smyth
Neil
N
Fuchs
Pawel
P
Pfister
Herbert
H
D000818:Animals; D005814:Genes, Viral / Q000235:genetics; D016158:Genes, p53 / Q000235:genetics; D053547:Keratin-14; D007633:Keratins / Q000235:genetics; D051379:Mice; D008811:Mice, Inbred DBA; D008822:Mice, Transgenic; D009154:Mutation; D027383:Papillomaviridae / Q000235:genetics*; D011401:Promoter Regions, Genetic; D012878:Skin Neoplasms / Q000235:genetics* / Q000473:pathology / Q000821:virology*; D014158:Transcription, Genetic
C507540:KRT14 protein, human; D053547:Keratin-14; C507446:Krt14 protein, mouse; D007633:Keratins